Achieve Your Weight Loss Goals with Saxenda

If you’re struggling with obesity or looking to shed excess pounds, Saxenda (liraglutide) offers a promising solution. This FDA-approved medication not only facilitates weight loss but also helps individuals maintain their weight after achieving their goals. Saxenda is designed for obese adults and overweight individuals who face additional health challenges linked to excess weight. Its efficacy is especially significant when paired with a healthy diet and regular exercise.

Who Can Benefit from Saxenda?

Saxenda is an excellent option for adults battling obesity, particularly those who have weight-related medical conditions such as type 2 diabetes, hypertension, or sleep apnea. Furthermore, it is also suitable for adolescents aged 12 to 17 years, provided they have a body weight exceeding 132 pounds (60 kg) and suffer from obesity. By utilizing Saxenda, young individuals can effectively tackle their weight issues at an early age, setting a foundation for healthier habits throughout life.

How Saxenda Works

Saxenda functions by mimicking the effects of a natural hormone in the body that regulates appetite and food intake. This makes it easier for users to feel satisfied after meals, thus reducing the likelihood of overeating. Saxenda’s ability to aid weight loss has been clinically backed, showing promising results for users aiming to improve their overall health. Remember, for optimal results, Saxenda should be used in conjunction with a balanced diet and a consistent exercise regimen, allowing you to not only lose weight but also maintain it long-term.

What is Saxenda used for?

Saxenda is FDA approved for weight loss and to help keep weight off once you have lost weight. It can be used for:

Adults:

• obese adults (BMI 30 kg/m2 or greater)
• overweight adults (BMI 27 kg/m2 or greater) who also have weight-related medical problems e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia.

Pediatric patients aged 12 years and older:

• body weight above 60 kg and
• their initial BMI corresponding to 30 kg/m2 or greater for adults (obese) by international cut-offs (Cole Criteria)

Warnings

The Victoza brand of liraglutide is used together with diet and exercise to treat type 2 diabetes. Do not use Saxenda and Victoza together.

You should not use Saxenda if you have multiple endocrine neoplasia type 2 (tumors in your glands), a personal or family history of medullary thyroid cancer, insulin-dependent diabetes, diabetic ketoacidosis, or are pregnant.

In animal studies, liraglutide caused thyroid tumors or thyroid cancer. It is not known whether these effects would occur in people using regular doses.

Call your doctor at once if you have signs of a thyroid tumor, such as swelling or a lump in your neck, trouble swallowing, a hoarse voice, or shortness of breath.

Before using Saxenda

You should not use Saxenda if you are allergic to liraglutide, or if you have:

• multiple endocrine neoplasia type 2 (tumors in your glands);
• a personal or family history of medullary thyroid carcinoma (a type of thyroid cancer); or
• diabetic ketoacidosis (call your doctor for treatment).

You should not use Saxenda if you also use insulin or other medicines like liraglutide (albiglutide, dulaglutide, exenatide, Byetta, Bydureon, Tanzeum, Trulicity).

To make sure Saxenda is safe for you, tell your doctor if you have:

• stomach problems causing slow digestion;
• kidney or liver disease;
• high triglycerides (a type of fat in the blood);
• heart problems;
• a history of problems with your pancreas or gallbladder; or
• a history of depression or suicidal thoughts
• are planning surgery or other procedure that uses anesthesia or deep sedation.

In animal studies, liraglutide caused thyroid tumors or thyroid cancer. It is not known whether these effects would occur in people using regular doses. Ask your doctor about your risk.

It is not known whether Saxenda will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.

It is not known whether liraglutide passes into breast milk or if it could affect the nursing baby. Tell your doctor if you are breast-feeding.

Saxenda is not FDA-approved for use by anyone younger than 18 years old.